# NM_000760.4(CSF3R):c.1407C>T (p.Ser469=)

https://sugi.bio/variant/csf3r-p-ser469

## Summary

**CSF3R p.Ser469= (c.1407C>T)** is classified **Likely benign** in CSF3R (ClinVar, Single submitter, 1 submitter; last evaluated 2025-04-21). Ultra-rare (popmax 0.0164%, mid); Associated with autosomal recessive severe congenital neutropenia due to CSF3R deficiency.

**At a glance:** Likely benign · review: Single submitter · rsID rs1306508815 · 1 submitter · 1 linked condition · ultra-rare (popmax 0.0164%, mid)

## For patients & families {#patients}

This is a change in the CSF3R gene that is classified as likely benign — not considered disease-causing, submitted by 1 submitter, and is linked to autosomal recessive severe congenital neutropenia due to CSF3R deficiency.

*Reference information, not medical advice, and not a prediction for any individual. A genetic counselor or clinician can interpret what it means for you and your family.*

|  |  |
| --- | --- |
| Typical inheritance (of this condition) | Autosomal recessive |
| Age of onset (of this condition) | Infancy, Neonatal |
| Diagnostic panels | CSF3R is a diagnostic-grade gene on 5 Genomics England panels |

**Support & next steps:** [Condition overview & support (NIH GARD)](https://rarediseases.info.nih.gov/diseases/0017698/index) · [Find a genetic counselor (NSGC)](https://findageneticcounselor.nsgc.org/).

## Identity {#identity}

| Field | Value |
| --- | --- |
| Gene | [CSF3R](https://sugi.bio/atlas/gene/CSF3R/) |
| Protein change (HGVS p.) | p.Ser469= |
| Coding change (HGVS c.) | c.1407C>T |
| MANE Select transcript | [NM_000760](https://www.ncbi.nlm.nih.gov/nuccore/NM_000760) |
| dbSNP | [rs1306508815](https://www.ncbi.nlm.nih.gov/snp/rs1306508815/) |
| Variant type | single nucleotide variant |
| Location | chr1:36469719-36469719 (GRCh38) |
| ClinVar | [VCV859944](https://www.ncbi.nlm.nih.gov/clinvar/variation/859944/) |

**All HGVS expressions:** `LRG_144:g.18190C>T`, `LRG_144t1:c.1407C>T`, `LRG_144t2:c.1407C>T`, `NC_000001.10:g.36935320G>A`, `NC_000001.11:g.36469719G>A`, `NG_016270.1:g.18190C>T`, `NM_000760.4:c.1407C>T`, `NM_156039.3:c.1407C>T`, `NM_172313.3:c.1407C>T`

## Computational & population evidence {#evidence}

**Concordance:** Mixed / partial computational evidence (see below).

- **Missense predictors (AlphaMissense/REVEL/SaProt) do not apply** to this variant type — they score amino-acid substitutions only. For non-missense variants the computational signal comes from conservation (below), not from a missing predictor score.
- Conservation: phyloP 1.111, GERP -0.595, phastCons 0.356 — weakly conserved position
- CADD: **PHRED 4.043**. No single ClinGen-calibrated threshold exists and the expert panels that use CADD disagree — GUCY2D/AIPL1 require ≥ 20.0 for an untranslated-region variant, ABCA4 ≥ 28.1 for a synonymous or indel variant, the Pulmonary Hypertension panel imports Pejaver 2022's missense-calibrated numbers, and the Antibody Deficiencies panel declines CADD entirely for PIK3CD. CADD v1.7 also incorporates Zoonomia phyloP, so it partly re-expresses the conservation above. *Descriptive; no threshold applied.*
- SpliceAI: **not assessed** — no allele at this position is in our SpliceAI release, either because it lies outside the scored MANE transcript scope or because every allele is below Δ0.2. We cannot tell which, so this claims neither; absence is not evidence against a splicing effect.
- Population frequency (gnomAD v4.1): grpmax **0.0164%** (mid) · FAF95 0.000359% · FAF99 0.00026% · 1/6,084 in the highest group · 12/1,614,056 alleles overall — ultra-rare (popmax 0.0164%, mid).

| Ancestry group | Allele frequency | 1 in |
| --- | --- | --- |
| Middle Eastern (grpmax) | 0.0164% | 6,084 |
| Remaining individuals (not grpmax-eligible) | 0.0016% | 62,486 |
| South Asian | 0.0011% | 91,090 |
| European (non-Finnish) | 0.000763% | 131,117 |

*Computational predictors are not independent (ClinGen Variant Classification guidance): AlphaMissense (Cheng et al. 2023) carries the ACMG weight for missense and conservation (phyloP/GERP/phastCons) for non-missense; REVEL (Pejaver-2022 calibrated strength bands) and SaProt (Su et al. 2023, structure-aware, ClinVar-independent protein language model, raw LLR) are shown as orthogonal agreement signals, not additive. For frequency, the gnomAD v4.1 grpmax filtering allele frequency (FAF95) is ClinGen's designated BA1/BS1 input (gnomAD v4 guidance v3.0, June 2025); BA1/BS1 thresholds are disease-specific, not a blanket 5%. Predictions, not a clinical determination.*

## Gene constraint & dosage {#gene-context}

**CSF3R** population constraint: LOEUF 0.726, pLI 3.6121e-09, missense-Z 2.4079. *Lower LOEUF and higher pLI indicate a gene that tolerates loss-of-function poorly; ClinGen dosage is the curated haploinsufficiency call.*

## Protein context {#protein}

Residue **469** lies in the fibronectin type-iii 4 domain.

AlphaFold model confidence (whole protein): pLDDT 74.29, 37% of residues very-high.

**1 experimental structure(s)** (PDB): [2D9Q](https://www.rcsb.org/structure/2D9Q).

## What this gene does {#gene-function}

*Describes the biological roles of CSF3R (the gene this variant disrupts) — not effects measured for this specific variant. A damaging variant is expected to affect these functions and pathways; the degree depends on the variant.*


### Pathways affected {#pathways}

CSF3R participates in **4 Reactome pathways** (⚕ = disease pathway):

| Pathway (Reactome) | Evidence |
| --- | --- |
| [Other interleukin signaling](https://reactome.org/content/detail/R-HSA-449836) | curated |
| [Inactivation of CSF3 (G-CSF) signaling](https://reactome.org/content/detail/R-HSA-9705462) | electronic |
| [Signaling by CSF3 (G-CSF)](https://reactome.org/content/detail/R-HSA-9674555) | electronic |
| [Transcriptional regulation of granulopoiesis](https://reactome.org/content/detail/R-HSA-9616222) | electronic |

## Clinical significance {#significance}

**Likely benign** — review status Single submitter *(criteria provided, single submitter)*, last evaluated 2025-04-21.

**Submitter consensus:** unanimous (1/1 Likely benign).

### Submitter classifications {#submitters}

| Submitter | Classification | Review | Method | Date |
| --- | --- | --- | --- | --- |
| Labcorp Genetics (formerly Invitae), Labcorp | Likely benign | criteria provided, single submitter | clinical testing | 2025-04-21 |

## Associated conditions {#conditions}

[autosomal recessive severe congenital neutropenia due to CSF3R deficiency](https://sugi.bio/atlas/disease/autosomal-recessive-severe-congenital-neutropenia-due-to-csf3r-deficiency/).

**Reported phenotype names (ClinVar):** Autosomal recessive severe congenital neutropenia due to CSF3R deficiency, Neutropenia, severe congenital, 7, autosomal recessive.

## Same-residue context {#hotspot}

Residue **469** carries **1 other pathogenic ClinVar variant** — a recurrently-mutated position: [CSF3R p.Ser469fs](/variant/csf3r-p-ser469fs). *Positional co-occurrence of independent ClinVar records, not functional proof.*

## Similar variants {#similar}

Related CSF3R variant pages (same residue, condition, or type): [CSF3R p.Ser469Ile](/variant/csf3r-p-ser469ile), [CSF3R p.Ser469fs](/variant/csf3r-p-ser469fs), [CSF3R c.1072-1G>A](/variant/csf3r-c-1072-minus-1g-a), [CSF3R c.843+2T>C](/variant/csf3r-c-843-plus-2t-c), [CSF3R c.998-2A>T](/variant/csf3r-c-998-minus-2a-t), [CSF3R p.Arg308Cys](/variant/csf3r-p-arg308cys), [CSF3R p.Arg440Ter](/variant/csf3r-p-arg440ter), [CSF3R p.Gln114Ter](/variant/csf3r-p-gln114ter).

### Data sources & attribution {#sources}

ClinVar (NCBI — public domain, built 2026-10-11); gnomAD v4.1 (Broad Institute, built 2026-10-06); AlphaMissense (Cheng et al. 2023, © Google DeepMind — CC BY 4.0, built 2026-01-27); REVEL (Ioannidis et al. 2016 — ODbL, built 2026-07-13); SaProt (Su et al. 2023 — MIT, built 2026-07-14); SpliceAI (Illumina — free for non-commercial use, built 2026-10-13); CADD (Rentzsch et al. 2019, University of Washington — free for non-commercial use, built 2026-10-10); Conservation (phyloP/phastCons/GERP) (UCSC hg38 470-way mammal (Hiller Lab) + Ensembl Compara, built 2026-07-12); gnomAD Non-coding Constraint (Gnocchi) (Chen et al. 2024, Broad Institute — CC0, built 2026-10-11); gnomAD Regional Missense Constraint (Broad Institute — CC0, built 2026-10-13); Pangolin (Zeng & Li 2022 — CC BY 4.0, built 2026-10-11); Repeat regions (UCSC — RepeatMasker, TRF, segmental duplications, built 2026-10-11); ClinGen (ClinGen, built 2026-09-22); UniProt (CC BY 4.0); Reactome / GO (CC BY 4.0, built 2026-09-23); MaveDB (per-record license, built 2026-10-11); CIViC (CC0, built 2026-09-22); Orphanet (Orphanet, built 2026-06-12)

*Primary record: NCBI ClinVar (variation 859944). Classifications reflect these databases as of the page's build date and may change. Free reference use — not medical advice; consult the primary submitters and a clinician.*